Mir Mohammad Ehsanul Haque

Mir Mohammad Ehsanul Haque

Auto-generated profile, based on publicly available information

Mir Mohammad Ehsanul Haque

Department of Biochemistry and Molecular Biology, Jagannath University, Dhaka, 1100, Bangladesh

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 November 2025 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
Sk. Faisal AhmedSk. Faisal Ahmed
Sk. Faisal Ahmed
PBProja Barua
Proja Barua
AAAl Amin
Al Amin
RTRahnuma Tabassum
Rahnuma Tabassum
MHMir Mohammad Ehsanul Haque
Mir Mohammad Ehsanul Haque
Abhishek Kumar VermaAbhishek Kumar Verma
Abhishek Kumar Verma

29 July 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
MHMir Mohammad Ehsanul Haque
Mir Mohammad Ehsanul Haque
CNChinmoy Nandi
Chinmoy Nandi
RTRahnuma Tabassum
Rahnuma Tabassum
MAMd Al Amin
Md Al Amin
AKAdittya Sabhayasachi Khan
Adittya Sabhayasachi Khan
MIMd. Rafiqul Islam
Md. Rafiqul Islam
The clinical manifestations of dengue virus (DENV) infections are classified as Neglected Tropical Diseases (NTDs) by the World Health Organization (WHO). About 20,000 people die each year in tropical and subtropical regions, and more than 2.5 billion individuals are at risk. Researchers have an eye on natural compounds for DENV treatment due to the lack of effective medications and a widely accepted vaccination. The DENV2 NS3 protein, with protease activity, is key for host cell viral replication. NS2B is linked with NS3 protein as a cofactor. Hence, NS2B-NS3 is a potential druggable target, because inhibiting this enzyme complex greatly reduces DENV-associated infection. Currently, there are some antiviral drugs with poor efficacy, which encourages the search for possible inhibitors of the DENV2 NS2B-NS3 protease using computational methods. This study aims to identify potential inhibitors against the DENV2 NS2B-NS3 protease using Molecular docking, ADMET analysis, MD simulation, MM/PBSA, QSAR and DFT calculations. A total of 5,841 phytochemicals, derived from 40 traditional medicinal plants, were screened against the NS2B-NS3 protease, with the compounds retrieved from the IMPPAT (Indian Medicinal Plants, Phytochemistry and Therapeutics) database. Two potential phytocompounds (CID 5204 and CID 99474) exhibited binding affinities of -9.7 and -9.4 kcal/mol, respectively, higher than the control compound. Furthermore, MD simulation of 200 ns validated the stability of these compounds when complexed with the target protein. This research identified promising new phytochemicals targeting DENV2 NS2B-NS3 protease, which may serve as potential leads for the development of effective antiviral drugs for dengue treatment.